Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Johansen

Showing results (521-530 of 592) with videos related to

Pageof 60
Sort By:
BMC Emergency Medicine|August 22, 2018
Cross sectional study of multiresistant bacteria in Danish emergency departments: prevalence, patterns and risk factors for colonization (AB-RED project)Christian B Mogensen, Helene Skjøt-Arkil, Annmarie T Lassen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 StudyAlice Markussen, Julia S Johansen, Finn O Larsen, et al.
Cancers|July 14, 2023
Epidemiological Study of Malignant Paediatric Liver Tumours in Denmark 1985-2020Thomas N Nissen, Catherine Rechnitzer, Birgitte K Albertsen, et al.
BMJ Open|June 30, 2019
Carrier prevalence and risk factors for colonisation of multiresistant bacteria in Danish emergency departments: a cross-sectional surveyHelene Skjøt-Arkil, Christian Backer Mogensen, Annmarie Touborg Lassen, et al.
Plos One|July 11, 2013
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic CancerNicolai A Schultz, Ib J Christensen, Jens Werner, et al.
Iscience|February 18, 2026
Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancerSonia Hermoso-Durán, David Ortega-Alarcon, Astrid Z Johansen, et al.
The Journal of Hospital Infection|September 9, 2019
Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelinesH Skjøt-Arkil, C B Mogensen, A T Lassen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Pageof 60

Showing results (521-530 of 592) with videos related to

Sort By:
Pageof 60
BMC Emergency Medicine|August 22, 2018
Cross sectional study of multiresistant bacteria in Danish emergency departments: prevalence, patterns and risk factors for colonization (AB-RED project)Christian B Mogensen, Helene Skjøt-Arkil, Annmarie T Lassen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 2, 2023
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R)Inna M Chen, Marco Donia, Christopher A Chamberlain, et al.
Cell Reports. Medicine|April 12, 2023
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancerVivek Nimgaonkar, Viswesh Krishna, Vrishab Krishna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2024
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 StudyAlice Markussen, Julia S Johansen, Finn O Larsen, et al.
Cancers|July 14, 2023
Epidemiological Study of Malignant Paediatric Liver Tumours in Denmark 1985-2020Thomas N Nissen, Catherine Rechnitzer, Birgitte K Albertsen, et al.
BMJ Open|June 30, 2019
Carrier prevalence and risk factors for colonisation of multiresistant bacteria in Danish emergency departments: a cross-sectional surveyHelene Skjøt-Arkil, Christian Backer Mogensen, Annmarie Touborg Lassen, et al.
Plos One|July 11, 2013
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic CancerNicolai A Schultz, Ib J Christensen, Jens Werner, et al.
Iscience|February 18, 2026
Integrating thermal liquid biopsy, clinical data, and mass spectrometry for early diagnosis and biomarker discovery in colorectal cancerSonia Hermoso-Durán, David Ortega-Alarcon, Astrid Z Johansen, et al.
The Journal of Hospital Infection|September 9, 2019
Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelinesH Skjøt-Arkil, C B Mogensen, A T Lassen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Pageof 60